A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease
Clinical trial NCT01281553 · TERMINATED
Trial details
- NCT number
- NCT01281553
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.